Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC
Clinical trial NCT04124991 · COMPLETED
Trial details
- NCT number
- NCT04124991
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-12
- Primary completion
- 2022-07-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.